Assignee
AREXIS AB
SE14 patents
Top patents by PatentIndex Score
US7872052B2Jan 18, 2011
Use of heterocyclic compounds as SCCE inhibitors
AREXIS AB16 citations82
US7214850B2May 8, 2007
Transgenic mouse expressing Prkag3
AREXIS AB6 citations72
US7208305B2Apr 24, 2007
Variants of the α1 subunit of human AMPK
AREXIS AB5 citations69
US11180542B2Nov 23, 2021
Stabilized liquid anti-RSV antibody formulations
AREXIS AB0 citations62
US7148020B2Dec 12, 2006
Triple polypeptide complexes
AREXIS AB4 citations53
US10604560B2Mar 31, 2020
Stabilized liquid anti-RSV antibody formulations
AREXIS AB0 citations51
US7858369B2Dec 28, 2010
Expression constructs expressing Prkag3
AREXIS AB0 citations51
US7943338B2May 17, 2011
Autoimmune conditions and NADPH oxidase defects
AREXIS AB0 citations49
US7294652B2Nov 13, 2007
Autoimmune conditions and NADPH oxidase defects
AREXIS AB1 citations49
US7476731B2Jan 13, 2009
Variants of the alpha 1 subunit of human AMPK
AREXIS AB0 citations47
US6465714B2Oct 15, 2002
Congenic animal models of non-insulin dependent diabetes mellitus
AREXIS AB6 citations46
US7452982B2Nov 18, 2008
Immunogenic complex
AREXIS AB1 citations38
US7462693B2Dec 9, 2008
Variants of the Gamma Chain of AMPX, DNA sequences encoding the same, and uses thereof
AREXIS AB0 citations36
US10625180B2Apr 21, 2020
Manufacturing method
AREXIS AB0 citations33